Navigation Links
Provia Laboratories, LLC Joins Stoneham Chamber of Commerce in Massachusetts
Date:5/8/2013

Lexington, MA (PRWEB) May 08, 2013

Provia Laboratories, LLC, a health services company specializing in high quality biobanking is pleased to announce that the company has joined the Stoneham Chamber of Commerce in Massachusetts.

“We are excited to have joined the ranks of many other member businesses who seek to promote and create economic growth and opportunity within the Stoneham community. Headquartered in Lexington, our company is looking forward to networking opportunities and building close relationships with our neighbors in Stoneham,” says Howard Greenman, CEO of Provia.

Provia Labs provides a service called Store-A-Tooth™, which preserves stem cells found in teeth whether they are from baby teeth that are naturally falling out, teeth removed for orthodontia, or wisdom tooth extractions. Similar to stem cells from bone marrow and umbilical cord blood, stem cells from teeth have the potential to be used in a broad range of medical applications and have already been shown to successfully regenerate dental bone and treat periodontal disease.

Backed by their extensive dental provider network and their continuous involvement within many different communities, Provia exhibited their Store-A-Tooth service at the Stoneham Health & Wellness Expo this past Saturday, May 4th, amongst a crowd of more than 1,000 attendees. Merrimack Valley Oral Surgery in Stoneham, a Store-A-Tooth provider, has tapped into the potential of regenerative medicine and is “dedicated to delivering an improved health and appearance through education, treatment, and friendly service in a comfortable environment."

They exhibited alongside Diane Bonanni DMD, a Stoneham family dentist and Commerce board member who offers the Store-A-Tooth service to her patients.
“As a dentist, I see tremendous value in offering this service to my patients. Each patient should know that they have this option, which could greatly benefit his or her future health. I look forward to a continued partnership with Store-A-Tooth and was excited to see everyone at the expo.”

-----

About Provia Laboratories, LLC

Provia Laboratories, LLC (http://www.provialabs.com) is a health services company specializing in high quality biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-Tooth™, gives families the option to store stem cells today to protect their children’s future health, so parents can take advantage of advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinson’s and Alzheimer’s.

For more information about Store-A-Tooth™ dental stem cell banking, please call 1-877-867-5753 or visit http://www.store-a-tooth.com.

For more information about Dianne Bonanni DMD and her Stoneham dental practice, please call 781-438-7900 or visit http://www.stonehamcosmeticdentist.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10714068.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
2. Provia Labs’ Store-A-Tooth™ Announces Top Expert in Stem Cell Biobanking as its Scientific Advisor
3. Grace Century Attends Provia Laboratories Cycle II Launch
4. MO BIO Laboratories, Inc. Launches the PowerMicrobiome™ RNA Isolation Kit
5. Frost & Sullivan Presents 2012 Clinical Diagnostics Company of the Year Award to GenPath Diagnostics of BioReference Laboratories, Inc.
6. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
7. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
8. MO BIO Laboratories, Inc. launches two new kits for high-throughput DNA isolation from plants and seeds
9. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
10. Robert Farrell Joins Bionovos Board of Directors
11. Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN JOSE, Calif. , Feb. 23, 2017 ... an exclusive license for two key immunotherapy technologies ... The first technology provides a method to monitor ... therapy such as PD-L1 and CTLA-4.  The second ... detect if a patient is likely to have ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Park ... free AFM Luncheon for all SPIE attendees and Park customers ... just one block from the San Jose Convention Center. The luncheon will feature ...
Breaking Biology Technology:
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/2/2017)... 2017  Central to its deep commitment to ... The Japan Prize Foundation today announced the laureates ... the envelope in their respective fields of Life ... are being recognized with the 2017 Japan Prize ... contribute to the advancement of science and technology, ...
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
Breaking Biology News(10 mins):